Beranda › Kanker (semua jenis) › Arkansas
Uji klinis Kanker (semua jenis) di Arkansas
22 studi untuk Kanker (semua jenis) mencari peserta di lokasi di Arkansas.
Kota di Arkansas
Teks studi resmi (Bahasa Inggris)
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Highlands Oncology Group - Springdale /ID# 277132, Springdale
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07155187Registry Study for Radiation Therapy Outcomes
- Proton Center of Arkansas, Little Rock
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT01255748A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Central Arkansas Radiation Therapy Institute, dba CARTI, Bryant
- Central Arkansas Radiation Therapy Institute, dba CARTI, Conway
- CARTI Cancer Center, Little Rock
- dan 2 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06756607A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Highlands Oncology Group, Springdale
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581Project: Every Child for Younger Patients With Cancer
- Arkansas Children's Hospital, Little Rock
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Arkansas Urology, Little Rock
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07480356Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Highlands Oncology Group - Fayetteville, Fayetteville
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
- dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Highlands Oncology Group - Springdale /ID# 267742, Springdale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05650632Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - FTS, Fort Smith
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07327489In Vivo Real-time Detection of Circulating Melanoma Cells
- University of Arkansas for Medical Sciences, Little Rock
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT01776905Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Central Arkansas Veterans Healthcare System , Little Rock, AR, Little Rock
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572Galleri® in the Medicare Population.
- Mercy Health - Fort Smith, Fort Smith
Menerima pesertaSukarelawan sehat diterima
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05673018A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
- Arkansas Children's, Little Rock
- Arkansas Children's Northwest, Springdale
Menerima pesertaStudi observasional
Usia 1 hingga 23 · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT07422337GEMINI-NSCLC: NSCLC Biomarker Study
- Mercy Clinic Oncology - Fort Smith, Fort Smith
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05236114Beat Childhood Cancer Specimen Banking and Data Registry
- Arkansas Children's Hospital, Little Rock
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT04715178Caris Biorepository Research Protocol
- St. Bernards Medical Center, Jonesboro
- CARTI Cancer Center, Little Rock
- ObjectiveHealth - ARcare Center for Clinical Research, Little Rock
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT01499394Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Michael Birrer, MD, PhD, Little Rock
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Nov 2025 · NCT05997017SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
- University of Arkansas for Medical Sciences, Little Rock
Menerima pesertaStudi observasional
Usia 30 ke atas · Wanita · Diperbarui 16 Sep 2025 · NCT04794322Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Mercy Clinic Oncology - Fort Smith, Fort Smith
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2025 · NCT05234177Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Arkansas for Medical Sciences, Little Rock
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.